< 返回主頁
by admin | 11月 18, 2020 | 重聞快遞-科學抗疫
類型: 連結 出處: Business Wire 連結: https://www.businesswire.com/news/home/20201118005595/en/Pfizer-and-BioNTech-Conclude-Phase-3-Study-of-COVID-19-Vaccine-Candidate-Meeting-All-Primary-Efficacy-Endpoints